Protein misfolding, functional amyloid, and human disease.

Peptides or proteins convert under some conditions from their soluble forms into highly ordered fibrillar aggregates. Such transitions can give rise to pathological conditions ranging from neurodegenerative disorders to systemic amyloidoses. In this review, we identify the diseases known to be associated with formation of fibrillar aggregates and the specific peptides and proteins involved in each case. We describe, in addition, that living organisms can take advantage of the inherent ability of proteins to form such structures to generate novel and diverse biological functions. We review recent advances toward the elucidation of the structures of amyloid fibrils and the mechanisms of their formation at a molecular level. Finally, we discuss the relative importance of the common main-chain and side-chain interactions in determining the propensities of proteins to aggregate and describe some of the evidence that the oligomeric fibril precursors are the primary origins of pathological behavior.

[1]  M. Amaral,et al.  CFTR and chaperones , 2007, Journal of Molecular Neuroscience.

[2]  C. Dobson,et al.  Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation. , 2006, Journal of molecular biology.

[3]  Jesper Søndergaard Pedersen,et al.  The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. , 2006, Journal of molecular biology.

[4]  Richard M. Page,et al.  Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease , 2005, Neuroscience.

[5]  S. Teichmann,et al.  The importance of sequence diversity in the aggregation and evolution of proteins , 2005, Nature.

[6]  S. Becker,et al.  Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Virgil L. Woods,et al.  Structure and properties of α-synuclein and other amyloids determined at the amino acid level , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Sarah A. Petty,et al.  Intersheet rearrangement of polypeptides during nucleation of β-sheet aggregates , 2005 .

[9]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[10]  C. Dobson,et al.  Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. , 2005, Journal of molecular biology.

[11]  S. Radford,et al.  Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. , 2005, Journal of molecular biology.

[12]  C. Dobson,et al.  Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. , 2005, Structure.

[13]  R. Wickner,et al.  Yeast prions [URE3] and [PSI+] are diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[15]  Naomi E Chayen,et al.  Methods for separating nucleation and growth in protein crystallisation. , 2005, Progress in Biophysics and Molecular Biology.

[16]  Thorsten Lührs,et al.  Correlation of structural elements and infectivity of the HET-s prion , 2005, Nature.

[17]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[18]  S. Lindquist,et al.  Structural insights into a yeast prion illuminate nucleation and strain diversity , 2005, Nature.

[19]  David T. Kaleta,et al.  Structural properties of Abeta protofibrils stabilized by a small molecule. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Shinya Honda,et al.  Higher-order molecular packing in amyloid-like fibrils constructed with linear arrangements of hydrophobic and hydrogen-bonding side-chains. , 2005, Journal of molecular biology.

[21]  Dennis C Winkler,et al.  Filaments of the Ure2p prion protein have a cross-β core structure , 2005 .

[22]  Ueli Aebi,et al.  The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.

[23]  P. Westermark,et al.  Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. M. Jones,et al.  Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion Amyloids , 2005, Cell.

[25]  J. Weissman,et al.  Mechanism of Cross-Species Prion Transmission An Infectious Conformation Compatible withTwo Highly Divergent Yeast Prion Proteins , 2005, Cell.

[26]  C. Pál,et al.  Molecular chaperones as regulatory elements of cellular networks. , 2005, Current opinion in cell biology.

[27]  C. Dobson,et al.  Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. , 2005, Journal of molecular biology.

[28]  Fabrizio Chiti,et al.  Investigating the Effects of Mutations on Protein Aggregation in the Cell* , 2005, Journal of Biological Chemistry.

[29]  Peter T Lansbury,et al.  Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Giampaolo Merlini,et al.  Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[31]  Thorsteinn Adalsteinsson,et al.  Correlations among morphology, beta-sheet stability, and molecular structure in prion peptide aggregates. , 2005, Biochemistry.

[32]  A. Darinskas,et al.  Does the Cytotoxic Effect of Transient Amyloid Oligomers from Common Equine Lysozyme in Vitro Imply Innate Amyloid Toxicity?* , 2005, Journal of Biological Chemistry.

[33]  C. Griesinger,et al.  Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Dobson,et al.  Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.

[35]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[36]  M. DePristo,et al.  Simultaneous determination of protein structure and dynamics , 2005, Nature.

[37]  Pawel Sikorski,et al.  Molecular basis for amyloid fibril formation and stability. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Alexandrescu Amyloid accomplices and enforcers , 2005, Protein science : a publication of the Protein Society.

[39]  M. Fändrich,et al.  FTIR reveals structural differences between native β‐sheet proteins and amyloid fibrils , 2004, Protein science : a publication of the Protein Society.

[40]  V. Subramaniam,et al.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. , 2004, Biochemistry.

[41]  C. Hall,et al.  Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Lisa D. Cabrita,et al.  Polyglutamine Expansion in Ataxin-3 Does Not Affect Protein Stability , 2004, Journal of Biological Chemistry.

[43]  Ralf Langen,et al.  Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling* , 2004, Journal of Biological Chemistry.

[44]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[45]  A. Miller,et al.  The formation of spherulites by amyloid fibrils of bovine insulin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[47]  Heather L. True,et al.  Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits , 2004, Nature.

[48]  M. R. Nilsson Techniques to study amyloid fibril formation in vitro. , 2004, Methods.

[49]  Michele Vendruscolo,et al.  Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.

[50]  Jesper Søndergaard Pedersen,et al.  Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. , 2004, Journal of molecular biology.

[51]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[52]  Ralf Langen,et al.  Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. P. Kirpichnikov,et al.  Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways. , 2004, Biochemistry.

[54]  C. Dobson,et al.  Observation of sequence specificity in the seeding of protein amyloid fibrils , 2004, Protein science : a publication of the Protein Society.

[55]  A. Cavalli,et al.  The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates , 2004, Protein science : a publication of the Protein Society.

[56]  Peter Chien,et al.  Emerging principles of conformation-based prion inheritance. , 2004, Annual review of biochemistry.

[57]  Andrey V Kajava,et al.  A model for Ure2p prion filaments and other amyloids: the parallel superpleated beta-structure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  V. Subramaniam,et al.  NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation , 2004, The EMBO journal.

[59]  V. Uversky,et al.  Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.

[60]  P. Decottignies,et al.  Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p. , 2004, Biochemistry.

[61]  M. Hoshino,et al.  Core and heterogeneity of beta2-microglobulin amyloid fibrils as revealed by H/D exchange. , 2004, Journal of molecular biology.

[62]  Ann-Shyn Chiang,et al.  Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease , 2004 .

[63]  R. Lerner,et al.  Metabolite-initiated protein misfolding may trigger Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  F. Chiti,et al.  Aggregation of the Acylphosphatase from Sulfolobus solfataricus , 2004, Journal of Biological Chemistry.

[65]  M. Papa,et al.  Fibrillogenesis and Cytotoxic Activity of the Amyloid-forming Apomyoglobin Mutant W7FW14F* , 2004, Journal of Biological Chemistry.

[66]  J. Kelly,et al.  Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Fabrizio Chiti,et al.  The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. , 2004, Journal of molecular biology.

[68]  G. Merlini,et al.  The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies , 2004, Journal of internal medicine.

[69]  L. Serpell,et al.  Structural characterisation of islet amyloid polypeptide fibrils. , 2004, Journal of molecular biology.

[70]  C. Dobson,et al.  High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Ying Xu,et al.  Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.

[72]  Zoya Ignatova,et al.  Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  E. Kandel,et al.  A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.

[74]  Fred E. Cohen,et al.  Therapeutic approaches to protein-misfolding diseases , 2003, Nature.

[75]  Bart Kahr,et al.  Imaging linear birefringence and dichroism in cerebral amyloid pathologies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Christopher M Dobson,et al.  Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  P. Hawkins,et al.  Amyloidosis: new strategies for treatment. , 2003, The international journal of biochemistry & cell biology.

[78]  U. Baxa,et al.  Architecture of Ure2p Prion Filaments , 2003, Journal of Biological Chemistry.

[79]  J. M. Scholtz,et al.  The role of protein stability, solubility, and net charge in amyloid fibril formation , 2003, Protein science : a publication of the Protein Society.

[80]  Ralf Langen,et al.  Structural Organization of α-Synuclein Fibrils Studied by Site-directed Spin Labeling* , 2003, Journal of Biological Chemistry.

[81]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[82]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[83]  Christopher M. Dobson,et al.  A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme , 2003, Nature.

[84]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[85]  C. Dobson,et al.  Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration. , 2003, Journal of Molecular Biology.

[86]  Dennis Claessen,et al.  A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. , 2003, Genes & development.

[87]  G. Raposo,et al.  Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis , 2003, The Journal of cell biology.

[88]  Christiane Ritter,et al.  Domain organization and structure–function relationship of the HET‐s prion protein of Podospora anserina , 2003, The EMBO journal.

[89]  J. Trojanowski,et al.  Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.

[90]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[91]  V. Uversky,et al.  Polycation‐induced oligomerization and accelerated fibrillation of human α‐synuclein in vitro , 2003 .

[92]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[93]  R. Tycko Insights into the amyloid folding problem from solid-state NMR. , 2003, Biochemistry.

[94]  J. Doucet,et al.  The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. , 2003, Journal of structural biology.

[95]  G. Damaschun,et al.  Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation. , 2003, Journal of molecular biology.

[96]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[97]  Robert G Griffin,et al.  Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[100]  J. Kelly,et al.  Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  Christopher M Dobson,et al.  The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.

[102]  Ralf Langen,et al.  Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling* , 2002, The Journal of Biological Chemistry.

[103]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[104]  M. Monti,et al.  Topological investigation of amyloid fibrils obtained from β2‐microglobulin , 2002, Protein science : a publication of the Protein Society.

[105]  David A. Lomas,et al.  Human genetics and disease: Serpinopathies and the conformational dementias , 2002, Nature Reviews Genetics.

[106]  J. J. Balbach,et al.  Supramolecular Structure in Full-Length Alzheimer's β-Amyloid Fibrils: Evidence for a Parallel β-Sheet Organization from Solid-State Nuclear Magnetic Resonance , 2002 .

[107]  F. Vollrath,et al.  Amyloidogenic nature of spider silk. , 2002, European journal of biochemistry.

[108]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[109]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Christopher M. Dobson,et al.  The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Christine Wurth,et al.  Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. , 2002, Journal of molecular biology.

[112]  S. Radford,et al.  The yeast prion Ure2p retains its native α‐helical conformation upon assembly into protein fibrils in vitro , 2002, The EMBO journal.

[113]  T. Iwatsubo,et al.  Biochemical Characterization of the Core Structure of α-Synuclein Filaments* , 2002, The Journal of Biological Chemistry.

[114]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[115]  J. Clarke,et al.  Sequence conservation in Ig-like domains: the role of highly conserved proline residues in the fibronectin type III superfamily. , 2002, Journal of molecular biology.

[116]  M. Hoshino,et al.  Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange , 2002, Nature Structural Biology.

[117]  Xin Wu,et al.  Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model , 2002, Nature Neuroscience.

[118]  J T Finch,et al.  Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[119]  Sebastian Doniach,et al.  Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.

[120]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[121]  V. Uversky Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.

[122]  James C. Sacchettini,et al.  Therapeutic strategies for human amyloid diseases , 2002, Nature Reviews Drug Discovery.

[123]  C. Dobson,et al.  Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme , 2002, Nature Structural Biology.

[124]  Christopher M. Dobson,et al.  Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.

[125]  Scott J. Hultgren,et al.  Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.

[126]  D. Raleigh,et al.  Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides : Implications for the study of amyloid formation , 2000 .

[127]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[128]  M. Sousa,et al.  Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. , 2001, The American journal of pathology.

[129]  G. Bitan,et al.  Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS* , 2001 .

[130]  R. Wetzel,et al.  Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. , 2001, Biochemistry.

[131]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[132]  G. Irvine,et al.  Aggregation and neurotoxicity of α-synuclein and related peptides , 2001 .

[133]  Rui M. M. Brito,et al.  Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants* , 2001, The Journal of Biological Chemistry.

[134]  V. Uversky,et al.  Is Congo Red an Amyloid-specific Dye?* , 2001, The Journal of Biological Chemistry.

[135]  J. King,et al.  Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues , 2001, Protein science : a publication of the Protein Society.

[136]  Y. Kallberg,et al.  Prediction of Amyloid Fibril-forming Proteins* , 2001, The Journal of Biological Chemistry.

[137]  C. Dobson,et al.  Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation , 2001, Protein science : a publication of the Protein Society.

[138]  M. Pepys Pathogenesis, diagnosis and treatment of systemic amyloidosis. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[139]  T. Konno Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril. , 2001, Biochemistry.

[140]  J. Mackay,et al.  The hydrophobin EAS is largely unstructured in solution and functions by forming amyloid-like structures. , 2001, Structure.

[141]  R. Wetzel,et al.  Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[142]  R. Leapman,et al.  Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils , 2000 .

[143]  H. True,et al.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.

[144]  S. Saupe,et al.  Molecular Genetics of Heterokaryon Incompatibility in Filamentous Ascomycetes , 2000, Microbiology and Molecular Biology Reviews.

[145]  D. Otzen,et al.  Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[146]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[147]  G. Vriend,et al.  Amyloids protect the silkmoth oocyte and embryo , 2000, FEBS letters.

[148]  D. Selkoe,et al.  The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. , 2000, Biochemistry.

[149]  L. Regan,et al.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[150]  L. Serpell,et al.  The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.

[151]  D. Foguel,et al.  The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[152]  S. Müller,et al.  Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation Inhibitors , 2000 .

[153]  C M Dobson,et al.  Mutational analysis of the propensity for amyloid formation by a globular protein , 2000, The EMBO journal.

[154]  M. Hecht,et al.  Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.

[155]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[156]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.

[157]  L Serrano,et al.  Protein engineering as a strategy to avoid formation of amyloid fibrils , 2000, Protein science : a publication of the Protein Society.

[158]  C M Dobson,et al.  Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy , 2000, Protein science : a publication of the Protein Society.

[159]  M. Schiffer,et al.  Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains , 2008, Protein science : a publication of the Protein Society.

[160]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[161]  C. Ionescu-Zanetti,et al.  Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[162]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[163]  Gary Lynch,et al.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.

[164]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[165]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[166]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[167]  J. Trojanowski,et al.  The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging , 1999, Experimental Neurology.

[168]  M. Tuite,et al.  Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion‐mediated mechanism , 1999, The EMBO journal.

[169]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[170]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[171]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[172]  I D Campbell,et al.  Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[173]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[174]  J. Kelly,et al.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.

[175]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[176]  R. Wickner,et al.  The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[177]  V. Coustou,et al.  The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[178]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[179]  U Aebi,et al.  Polymorphic fibrillar assembly of human amylin. , 1997, Journal of structural biology.

[180]  Peter T. Lansbury,et al.  Observation of metastable Aβ amyloid protofibrils by atomic force microscopy , 1997 .

[181]  Satoru Suzuki,et al.  Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .

[182]  C. Blake,et al.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction. , 1997, Advances in protein chemistry.

[183]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[184]  S. Paushkin,et al.  Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor. , 1996, The EMBO journal.

[185]  C. Bergeron,et al.  Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability. , 1996, The American journal of pathology.

[186]  U Aebi,et al.  Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. , 1995, Journal of structural biology.

[187]  S. Squazzo,et al.  Aggregation of Secreted Amyloid -Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture (*) , 1995, The Journal of Biological Chemistry.

[188]  P. Lansbury,et al.  The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.

[189]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[190]  H. Gertz,et al.  Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease , 1994, Brain Research.

[191]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[192]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.